Coartem® (artemether-lumefantrine) Baby becomes first malaria treatment approved for newborn babies and young infants Rapid approvals in eight African countries now expected under a special global ...

As Chief Audit Officer of Novartis, Teresa and her team provide risk-based assurance and advice on key strategic topics to the Board and management, acting as a key partner to the organization to help ...

Novartis has been serving patients in Indonesia for more than 50 years, through our predecessor companies, Ciba and Sandoz.

The trial will evaluate efficacy, safety and tolerability of two regimens of ianalumab compared to placebo, given as monthly or quarterly subcutaneous (s.c.) injection on top of standard-of-care (SoC) ...

Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.

Basel, June 25, 2025 – Novartis today announced that it has successfully completed its acquisition of Regulus Therapeutics Inc. (“Regulus”). With the completion of the acquisition, shares of common ...

Treating advanced prostate cancer demands more than clinical progress—it demands a new era of care, fueled by relentless innovation, collaborative efforts, and an unwavering push toward personalized ...

Despite endocrine therapy (ET), the risk of recurrence for people diagnosed with hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative (HER2-) early breast cancer (eBC) ...

【報道関係者各位】ノバルティス ファーマ株式会社の2025年6月24日付けプレスリリース『ノバルティス ファーマとがん研有明病院が治験に関する戦略的パートナーシップ協定を締結 ― 患者さんの治験への参加機会の拡大と効率化を目指す新たな協力体制 ―』です。

this week to discuss new ideas to transform healthcare. Our Novartis leaders engaged in discussions showcasing the company's scientific breakthroughs—and shared something just as urgent: The story of ...

Hof bevestigt uitspraak: Inkoopprocedure CDK4/6-remmers onrechtmatig 27 juni 2025 In de rechtszaak van Novartis tegen de zorgverzekeraars over de inkoopprocedure voor CDK4/6-remmers (palbociclib, ...

主な役割責任早期化合物の安全性評価を行いチームへ適切に評価内容を伝える。承認申請資料を作成し，当局からの照会回答を含む承認申請全般に責任をもつ。治験届に関する資料作成を行い，当局からの照会対応を含む治験届業務全般に責任をもつ。当局に対する相談について非臨床安全性 ...